• 西安醫(yī)科大學(xué)第一臨床醫(yī)學(xué)院肝膽外科研究室(西安710061);

引用本文: 石景森. 原發(fā)性肝癌栓塞化療術(shù). 中國普外基礎(chǔ)與臨床雜志, 1998, 5(4): 237-238. doi: 復(fù)制

1. Goldstein HM, Wallace S, Anderson JH. Transcatheter occlusion of abdominal tumors. Radiology, 1976; 120(3)∶539.
2. 石景森.原發(fā)性肝癌栓塞化療決策中的一些問題.普外基礎(chǔ)與臨床雜志,1995; 2(1)∶36.
3. 陸才德.肝臟腫瘤血供.國外醫(yī)學(xué)腫瘤分冊,1991;18(1)∶19.
4. Ng TOL, Lai ECS, Fan ST, et al. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer, 1994; 73(9)∶228.
5. 盧云,石景森,宋蔚青.中晚期肝癌綜合治療63例臨床分析.中國實用外科雜志,1997; 17(1)∶32.
6. 王建華.肝癌介入治療的進(jìn)展.臨床,1996; 3(1)∶28.
7. Bismuth H, Morimo M, Sherloch D,et al. Primary treatment of hepatoceullular carcinoma by arterial chemoembolization. Am J Surg, 1992; 163(4)∶387.
8. 盧云,石景森.肝動脈栓塞化療術(shù)后死亡病例31例.華人消化雜志,1998; 6(1)∶6.
  1. 1. Goldstein HM, Wallace S, Anderson JH. Transcatheter occlusion of abdominal tumors. Radiology, 1976; 120(3)∶539.
  2. 2. 石景森.原發(fā)性肝癌栓塞化療決策中的一些問題.普外基礎(chǔ)與臨床雜志,1995; 2(1)∶36.
  3. 3. 陸才德.肝臟腫瘤血供.國外醫(yī)學(xué)腫瘤分冊,1991;18(1)∶19.
  4. 4. Ng TOL, Lai ECS, Fan ST, et al. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer, 1994; 73(9)∶228.
  5. 5. 盧云,石景森,宋蔚青.中晚期肝癌綜合治療63例臨床分析.中國實用外科雜志,1997; 17(1)∶32.
  6. 6. 王建華.肝癌介入治療的進(jìn)展.臨床,1996; 3(1)∶28.
  7. 7. Bismuth H, Morimo M, Sherloch D,et al. Primary treatment of hepatoceullular carcinoma by arterial chemoembolization. Am J Surg, 1992; 163(4)∶387.
  8. 8. 盧云,石景森.肝動脈栓塞化療術(shù)后死亡病例31例.華人消化雜志,1998; 6(1)∶6.